HM
GBT

Harvest Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Harvest Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-141,500
Closed -$9.64M – 80
2022
Q3 		$9.64M Buy
+141,500
New +$7.8M 7.78% 2

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Harvest Management's GBT Position: Q4 2022 in Review

Harvest Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 141,500 shares — an estimated $9.64M sold.

Harvest Management first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $9.64M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Harvest Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Harvest Management sold 141,500 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $9.64M.
  • Harvest Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
  • Harvest Management's Global Blood Therapeutics, Inc. position peaked at $9.64M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Harvest Management's 13F filing for Q4 2022, filed 14 Feb 2023.